| Description: | Docetaxel and prednisone are standard treatments for advanced prostate cancer. Researchers want see if adding cabozantinib to these two drugs can be a safe and effective treatment for this type of cancer. |
|---|
| Link: | http://clinicaltrials.gov/ct2/show/NCT01683994 |
|---|---|
| Site: | NIH |
| Principal Investigator: | William L Dahut, M.D. |